In bladder cancer, ANXA11 expression levels were decreased in tumor tissue compared to the normal counterpart, and together with other annexins, serves to identify luminal-subtype bladder tumors (Wu et al., 2021). Here, ANXA11 is linked to urinary bladder carcinoma.